EGF receptor-targeted therapy in non-small-cell lung cancer: role of germline polymorphisms in outcome and toxicity.
Galvani, Elena
EGF receptor-targeted therapy in non-small-cell lung cancer: role of germline polymorphisms in outcome and toxicity. [electronic resource] - Future oncology (London, England) Aug 2012 - 1015-29 p. digital
Publication Type: Journal Article; Review
1744-8301
10.2217/fon.12.89 doi
Antineoplastic Agents--adverse effects
Carcinoma, Non-Small-Cell Lung--drug therapy
ErbB Receptors--antagonists & inhibitors
Erlotinib Hydrochloride
Gefitinib
Germ-Line Mutation
Humans
Polymorphism, Genetic
Protein Kinase Inhibitors--adverse effects
Quinazolines--adverse effects
Treatment Outcome
EGF receptor-targeted therapy in non-small-cell lung cancer: role of germline polymorphisms in outcome and toxicity. [electronic resource] - Future oncology (London, England) Aug 2012 - 1015-29 p. digital
Publication Type: Journal Article; Review
1744-8301
10.2217/fon.12.89 doi
Antineoplastic Agents--adverse effects
Carcinoma, Non-Small-Cell Lung--drug therapy
ErbB Receptors--antagonists & inhibitors
Erlotinib Hydrochloride
Gefitinib
Germ-Line Mutation
Humans
Polymorphism, Genetic
Protein Kinase Inhibitors--adverse effects
Quinazolines--adverse effects
Treatment Outcome